Almac Group

Mission

Partnering to Advance Human Health A unique culture delivering exceptional solutions: Almac is a financially secure, privately owned organisation with 7,300 employees globally. 600+ companies worldwide, including all the market leaders, use our services, testament itself to the quality, innovation and efficiency of our business as proven over the past 50 years. Our vast range of services include: Biomarker Discovery & Development: Pre-clinical biomarker discovery, through to full companion diagnostic development and clinical test delivery from our CLIA lab. API Services & Chemical Development: Services for all stages of drug development for small molecules, potent and cytotoxic compounds and peptides. Pharmaceutical Development: Developing clinical candidates into an optimum formulation and manufacturing drug product for all phases of clinical trial supply. Analytical Services: Delivering comprehensive solutions supporting drug substance and product development programmes. Clinical Trial Supply: Comprehensive global clinical supply chain solutions providing physical resources and supportive technologies ensuring your clinical supply chain continually delivers across the globe. Clinical Technologies: Providing randomisation and trial supply management technology, electronic Clinical Outcome Assessments (eCOA), patient alerts and reminders, data integration and biostatistical consulting services. Commercial Services: Providing commercial manufacturing and packaging solutions and supporting commercial product launch.